These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14698141)

  • 1. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine.
    Kjaergaard J; Shimizu K; Shu S
    Cell Immunol; 2003 Oct; 225(2):65-74. PubMed ID: 14698141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells.
    Kuriyama H; Shimizu K; Lee W; Kjaergaard J; Parkhurst MR; Cohen PA; Shu S
    Dev Biol (Basel); 2004; 116():169-78; discussion 179-86. PubMed ID: 15603192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic immune response induced by electrofusion of dendritic and tumor cells.
    Tanaka H; Shimizu K; Hayashi T; Shu S
    Cell Immunol; 2002 Nov; 220(1):1-12. PubMed ID: 12718934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
    Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE
    Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion.
    Hayashi T; Tanaka H; Tanaka J; Wang R; Averbook BJ; Cohen PA; Shu S
    Clin Immunol; 2002 Jul; 104(1):14-20. PubMed ID: 12139943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.
    Kuriyama H; Watanabe S; Kjaergaard J; Tamai H; Zheng R; Weinberg AD; Hu HM; Cohen PA; Plautz GE; Shu S
    Cell Immunol; 2006 Sep; 243(1):30-40. PubMed ID: 17207783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
    Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
    J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy.
    Shimizu K; Kuriyama H; Kjaergaard J; Lee W; Tanaka H; Shu S
    J Immunother; 2004; 27(4):265-72. PubMed ID: 15235387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells.
    Siders WM; Vergilis KL; Johnson C; Shields J; Kaplan JM
    Mol Ther; 2003 Apr; 7(4):498-505. PubMed ID: 12727113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
    Yasuda T; Kamigaki T; Kawasaki K; Nakamura T; Yamamoto M; Kanemitsu K; Takase S; Kuroda D; Kim Y; Ajiki T; Kuroda Y
    Cancer Immunol Immunother; 2007 Jul; 56(7):1025-36. PubMed ID: 17131118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
    Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
    Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.
    Kjaergaard J; Wang LX; Kuriyama H; Shu S; Plautz GE
    J Neurosurg; 2005 Jul; 103(1):156-64. PubMed ID: 16121986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine.
    Orentas RJ; Schauer D; Bin Q; Johnson BD
    Cell Immunol; 2001 Oct; 213(1):4-13. PubMed ID: 11747351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapeutic reactivity of dendritic cells loaded with a variety of antigen preparations].
    Shimizu K; Kuriyama H; Tamai H; Ueda Y; Yamagishi H; Shu S
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1637-9. PubMed ID: 15553668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.